United States News Todas as matérias

Intuit (NASDAQ:INTU) reported fiscal 2026 revenue of $21.4 billion, up 14% year over year, with higher revenue across its Global Business Solutions, Online Ecosystem, and Consumer businesses.

SpaceX (NASDAQ:SPCX) announced plans to launch its first AI-powered satellite systems in Q4 2027, with the company developing orbital computing infrastructure using Nvidia (NASDAQ:NVDA) technology.

Formula Systems (NASDAQ:FORTY) reported second-quarter 2026 revenue of $782.4 million, a record level and a 29.8% increase year over year, with higher operating income and shareholder earnings from continuing operations.

Huntsman (NYSE:HUN) and Olin (NYSE:OLN) announced that shareholders of both companies approved proposals required to complete their all-stock merger of equals, which will create OlinHuntsman Corporation.

BeOne Medicines (NASDAQ:ONC) received U.S. FDA approval for TEVIMBRA (tislelizumab) combined with ZIIHERA (zanidatamab) and chemotherapy as a first-line treatment for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma.

Jazz Pharmaceuticals (NASDAQ:JAZZ) received U.S. Food and Drug Administration approval for two Ziihera (zanidatamab-hrii) treatment regimens for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma.

Anavex Life Sciences (NASDAQ:AVXL) reported third fiscal quarter 2026 results and provided updates on blarcamesine development programs targeting Alzheimer’s disease, Rett syndrome, and Fragile X syndrome.

Vyome Holdings (NASDAQ:HIND) reported second-quarter 2026 results and provided a corporate update, highlighting progress on VT-1953, its lead program for symptoms associated with malignant fungating wounds.

OrthoPediatrics (NASDAQ:KIDS) announced the full commercial launch of its 3P Pediatric Plating Platform Hip System in the United States after a limited launch phase that included more than 350 surgical implantations.

BioCryst (NASDAQ:BCRX) announced that Japan’s Ministry of Health, Labor and Welfare approved once-daily ORLADEYO (berotralstat) as a preventive treatment for pediatric hereditary angioedema (HAE) patients aged 2 to under 12 years.

Sagimet Biosciences (NASDAQ:SGMT) reported progress on its AURORA U.S. Phase 3 clinical trial evaluating denifanstat, a FASN inhibitor being developed for moderate to severe acne.

Beyond Air (NASDAQ:XAIR) entered a definitive agreement for UNIVO Pharmaceutical Industries to acquire control of NeuroNOS Israel, a neurology-focused biopharmaceutical company in which Beyond Air owns approximately 58% of fully diluted shares.

The Bank of Nova Scotia (NYSE:BNS) reported fiscal third-quarter 2026 net income of C$2.95 billion, up from C$2.53 billion a year earlier, with higher revenue and earnings growth across business segments.

Lotus Technology (NASDAQ:LOT) completed the acquisition of 100% of the equity interests in Lotus Advance Technologies Sdn Bhd, known as Lotus UK, bringing its British sports car operations and engineering capabilities under a single corporate structure.

McKesson (NYSE:MCK) agreed to acquire Precision Medicine Group for approximately $2.25 billion, adding clinical research and biopharma commercialization services to its oncology and multispecialty operations.

The Marzetti Company (NASDAQ:MZTI) reported fiscal fourth-quarter 2026 net sales of $465 million, down 2.2% year over year, while adjusted diluted EPS increased 9% to $1.46.

Summit Therapeutics (NASDAQ:SMMT) announced publication of primary analysis results from the Phase III HARMONi clinical trial, showing ivonescimab combined with chemotherapy improved progression-free survival in patients with EGFR-mutated advanced non-small cell lung cancer.

Kanzhun (NASDAQ:BZ) reported second-quarter 2026 revenue of RMB2,398.6 million, up 14.1% year over year, driven by higher online recruitment revenue and growth in enterprise customers and users.

SelectQuote (NYSE:SLQT) reported fourth-quarter fiscal 2026 revenue of $321.7 million, with adjusted EBITDA of $11.9 million, while providing fiscal 2027 guidance for revenue between $1.35 billion and $1.45 billion.

DICK'S Sporting Goods (NYSE:DKS) unveiled second-quarter consolidated net sales of $5.59 billion, marking a 53.2% year-over-year increase.

Citi Trends (NASDAQ:CTRN) reported second-quarter 2026 sales of $211.6 million, up 10.9% from the prior-year period, driven by higher comparable store sales, transaction count, and average basket size.

Nayax (NASDAQ:NYAX) agreed to acquire IPS Group from Windjammer Capital for $350 million cash-free and debt-free, adding a smart parking technology platform serving municipalities, universities, and parking operators.

SCHMID Group (NASDAQ:SHMD) reported first-half 2026 revenue of €46 million, compared with €16.9 million in H1 2025, while improving adjusted EBITDA and expanding its order backlog.

Accenture (NYSE:ACN) agreed to acquire McCoy, a Netherlands-based SAP transformation consultancy, to expand its Accenture Edge business and strengthen support for mid-market companies adopting SAP and artificial intelligence solutions.